Search
Acrizanib
go.drugbank.com/drugs/DB16081InvestigationalAcrizanib is under investigation in clinical trial NCT02355028 (LHA510 Proof-of-concept Study as a Maintenance Therapy for Patients With Wet Age-related Macular Degeneration).
Categories: Compounds used in a research, industrial, or household settingIncadronic acid
go.drugbank.com/drugs/DB06255ExperimentalIncadronate, or YM-175,[A202769] is a nitrogen containing bisphosphonate.
Tipifarnib
go.drugbank.com/drugs/DB04960InvestigationalIn June 2005, the FDA issued a Not Approvable Letter for Zarnestra.
CHF 4227
go.drugbank.com/drugs/DB05882ExperimentalCHF 4227 is a new selective estrogen receptor modulator (SERM). The compound has a high receptor affinity and has shown promising efficacy in the prevention of bone loss in animal models of osteoporosis. Additionally, the compound has sh...
RPI-MN
go.drugbank.com/drugs/DB17957Experimental[A260132] Being developed by Nutra Pharma under the trade name PEPTERON, it is being investigated for the treatment of neurological and immune disorders.[L47107] … RPI-MN is a detoxified or chemically modified alpha-cobratoxin with antiviral properties.
Sulforaphane
go.drugbank.com/drugs/DB12422InvestigationalSulforaphane is under investigation for the treatment of Autism Spectrum Disorder. It is a naturally occurring isothiocyanate found in high concentration in a variety of broccoli.
Categories: Compounds used in a research, industrial, or household settingOxyphenbutazone
go.drugbank.com/drugs/DB03585ApprovedWithdrawnOxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.
Categories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical UseCefodizime
go.drugbank.com/drugs/DB13470InvestigationalCefodizime is a third generation cephalosporin with a broad spectrum of antibacterial activity.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseDimethylthiambutene
go.drugbank.com/drugs/DB01444ExperimentalIllicitIt is now under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential, although little more information is available.
TL-895
go.drugbank.com/drugs/DB16471InvestigationalTL-895 is under investigation in several clinical trials for its safety and efficacy in various conditions: NCT04419623 (completed, COVID-19 in cancer patients), NCT02825836 (active, not recruiting, B
Categories: Experimental Unapproved Treatments for COVID-19